CD4 and Autoimmunity: Importantly, UMCD6 is known to block T-cell-dependent autoimmunity through effects on differentiation of effector CD4+ T cell subsets, opening a new approach to cancer immunotherapy that will suppress rather than instigate immune-adverse related events [95].